Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Migraine Attack Study of Treatment, Efficacy and Resource Use (MASTER) - McKesson Substudy (MK-0974-076)

NCT01421277 is registered in ClinicalTrials.gov with Merck Sharp & Dohme LLC as lead sponsor.

NCT NCT01421277
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01421277 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Migraine Attack Study of Treatment, Efficacy and Resource Use (MASTER) - McKesson Substudy (MK-0974-076)
Lead sponsor
Merck Sharp & Dohme LLC
Phase
Observational
Overall status
Terminated
Start date
May 19, 2011
Completion date
March 23, 2012
Enrollment
216 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

migraine